Chronic, Active Inflammation in Patients With Failed Total Knee Replacements Undergoing Revision Surgery

Area of Science:

• Orthopedics
• Immunology
• Biochemistry

Background:

• Chronic pain and limited knee motion are common after total knee arthroplasty (TKA).
• The underlying molecular causes of post-TKA pain are not well understood, and effective targeted treatments are lacking.
• Inflammation is a potential contributor to persistent pain following TKA.

Purpose of the Study:

• To investigate the presence and levels of pro-inflammatory mediators in patients undergoing revision TKA.
• To determine if elevated inflammatory markers correlate with pain and indicate an ongoing inflammatory process.
• To identify specific inflammatory markers that could serve as targets for future therapies.

Main Methods:

• Measurement of twelve key inflammatory markers (cytokines, chemokines, angiogenesis, and cell migration mediators) in knee tissue and synovial fluid.
• Comparison of marker levels between primary TKA patients and revision TKA patients with various indications (loosening, stiffness, laxity, OA progression).
• Correlation analysis of marker levels with pain scores (WOMAC) and time since primary surgery.

Main Results:

• Revision TKA patients exhibited significantly higher levels of all measured pro-inflammatory mediators compared to primary TKA patients.
• Elevated marker levels in revision patients persisted regardless of the time elapsed since the primary surgery.
• No significant differences in marker levels were observed among different indications for revision surgery.
• Pain levels (WOMAC scores) were higher in revision patients than in primary patients.

Conclusions:

• The elevation of pro-inflammatory mediators in painful revision TKA knees suggests an active, chronic inflammatory state.
• These findings provide a rationale for developing targeted anti-inflammatory therapies for patients experiencing persistent pain after TKA.
• Identifying specific upregulated markers offers potential therapeutic targets, even for pain occurring many years after the initial joint replacement.